Blood cancers involve disruptions of the hematopoietic and immune systems, leading to a variety of hematologic malignancies. Leukemia, lymphoma (Hodgkin and non-Hodgkin) and myeloma are the three major categories of blood cancer. Flow cytometry immunophenotyping is a critical diagnostic step in blood cancers. We offer a wide array of tools, including powerful clinical cell analyzers and single-color monoclonal antibodies with many color options, for immunophenotyping and analysis of blood cancers.
Enumerating residual leukocytes in leukoreduced blood products is critical to ensure the quality of blood components. Flow cytometry is an effective counting method for evaluating leukoreduced products. BD Biosciences offers clinical flow cytometers and assays for enumerating residual leukocytes in leukoreduced blood products.
For many hematopoietic malignancies, collection and infusion of CD34+ hematopoietic stem/progenitor cells following chemotherapy is critical. An accurate measurement of CD34 is important for dose requirement protocols in stem cell transplantation. We offer clinical flow cytometers and assays, such as the BD® Stem Cell Enumeration (SCE) Kit, for enumerating CD34+ cells.
Alterations in the innate or adaptive arms of the immune system can lead to immune deficiencies. The most prominent secondary immune infection, acquired immune deficiency syndrome (AIDS), results from infection with human immunodeficiency virus (HIV). HIV specifically infects and reduces the number of CD4+ subsets of T lymphocytes. BD Biosciences offers robust clinical solutions for assessment of lymphocyte populations in persons living with HIV.
In autoimmune disorders the immune system overresponds against one’s own antigens. This failure to distinguish between self from nonself arises from breach of immune tolerance, the preventative mechanisms the immune system has in place to prevent attacking itself. Autoimmune diseases, such as ankylosing spondylitis, are caused by dysfunction in immune responses. BD Biosciences provides a tool for detecting HLA-B27, which is used to screen for ankylosing spondylitis, a rheumatic disorder. Our clinical BD® HLA-B27 Kit offers rapid detection of HLA-B27 antigen expression in erythrocyte-lysed whole blood using the BD FACSCalibur™ and BD FACSCanto™ Flow Cytometers.
HLA-B27 test is not for use in tissue typing.
COVID-19 T Cells
BD Biosciences provides tools that can be used as an aid in determining the risk of intubation with mechanical ventilation, and the risk of mortality in confirmed COVID-19 patients, in conjunction with clinical findings and the results of other laboratory testing. Explore our reagent, instrument, and data analysis solutions, as well as scientific resources and support.
BD Biosciences provides resources that can help you learn more about CD4 testing. We provide instrument options for complete CD4 testing, and assays, tubes and reagents for determining percentage and absolute counts of human lymphocyte subsets in peripheral whole blood.
BD® Stem Cell Enumeration Kit, BD® HLA-B27 Kit and BD FACSCanto™ II Flow Cytometer are CE marked in compliance with the European In Vitro Diagnostic Medical Device Directive 98/79/EC.
BD Flow Cytometers are Class 1 Laser Products.
BD FACSCalibur™ instrument is discontinued.
BD FACSCanto™ Flow Cytometer (10-color configuration) is discontinued in EU.